Skip to main content
David McKenna Jr., MD, Pathology, Minneapolis, MN, M Health Fairview University of Minnesota Medical Center

DavidHurleyMcKennaJr.MD

Pathology Minneapolis, MN

Blood Banking & Transfusion Medicine, Transplantation Immunology, Anatomic Pathology, Clinical Pathology

Professor, Lab Medicine & Pathology, University of Minnesota Medical School

Dr. McKenna is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. McKenna's full profile

Already have an account?

Summary

  • Dr. David McKenna is a pathologist in Saint Paul, MN. He received his medical degree from Saint Louis University School of Medicine and has been in practice 20 years. He specializes in blood banking & transfusion medicine, transplantation immunology, anatomic pathology, and clinical pathology and is experienced in hematopoietic stem cell transplantation and cellular immunity.

Education & Training

  • University of Minnesota
    University of MinnesotaFellowship, Transfusion Medicine, 2001 - 2003
  • University of Minnesota
    University of MinnesotaResidency, Pathology-Anatomic and Clinical, 1997 - 2003
  • Saint Louis University School of Medicine
    Saint Louis University School of MedicineClass of 1997

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 2003 - 2024
  • VT State Medical License
    VT State Medical License 1997 - 1998
  • American Board of Pathology Anatomic Pathology & Clinical Pathology
  • American Board of Pathology Blood Banking/Transfusion Medicine

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Mgta-456, an Aryl Hydrocarbon Receptor (AHR) Antagonist Based Expansion of CD34+ Hematopoietic Stem Cells (HSC), Permits Selection of Better HLA Matched Cord Blood Uni...
    David H. McKenna, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Results of a Phase 1 Trial of Gda-201, Nicotinamide-Expanded Allogeneic Natural Killer Cells (NAM-NK) in Patients with Refractory Non-Hodgkin Lymphoma (NHL) and Multip...
    David H. McKenna, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • Groundbreaking U of M Medical School Muscle Regeneration Research Receives Nearly $1 Million Grant
    Groundbreaking U of M Medical School Muscle Regeneration Research Receives Nearly $1 Million GrantSeptember 3rd, 2019

Hospital Affiliations